Brain scan concept

Healthcare disruptor Compumedics clocks record sales in 1H FY26 at $33M; revenue up +32%

Compumedics has posted its highest-ever sales figure, netting $33M in the first half of FY26, also…
Chinese health market concept

Telix jumps on maiden Chinese application for prostate imaging agent, but short selling increasing

Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate
FDA cpmce[t

Mesoblast dips on confusion around FDA advice on stem cells for back pain

Mesoblast (ASX:MSB) has seen its shares dip on Monday morning out the gate as some investors struggle to digest
Kuala Lumpur skyline

ReNerve jumps as flagship medtech approved in Malaysia, but gains pare in rush hour

ReNerve initially had a strong green run Thursday morning but by rush hour shares had pared…
Man holds Aus notes

4DMedical reportedly raising $150M at $3.80/sh; ASX 200 inclusion possible

4DMedical has startled some HotCopper forum users as it stages a $150 million capital raising at…
FDA Approval

Imricor Medical Systems runs hard on FDA greenlight for diagnostic catheter

Imricor has won its first keystone FDA clearance, with the U.S. regulator effectively thumbs-upping Imricor's diagnostic…
Australian currency cash

Mesoblast back to record highs as Ryoncil sales jump 60% QoQ to US$35M

Mesoblast is back onto investors' radars with good tidings from its sale of Ryoncil, with that…
AI image of a lung cross section

4DX up another 15% on new demo delivery; now boasting $2.5B cap & no revenue

4DMedical has climbed to a lofty valuation just short of $4.80 on Wednesday, bringing the biotech…
Knee joint injection with hyaluronic acid for osteoarthritis treatment. Medical procedure using syringe in sterile hospital environment. Professional orthopedic therapy for joint pain relief.

Paradigm Biopharma rolls into CY26 on patient tailwinds after hitting 25% recruitment milestone

Late-stage drug developer Paradigm Biopharmaceuticals is preparing for a huge CY26 after landing a key recruitment…
Memphasys (ASX:MEM) Felix™ System

Memphasys locks down 5-year European IVF supply deal

Memphasys has this week executed a long-term European commercial supply agreement with Centro Fertilita Assistita (CFA)…